Trial of Metformin-Clemastine Combo Enrolls First Patient & The High Cost of Living With MS episode artwork

EPISODE · May 4, 2022 · 9 MIN

Trial of Metformin-Clemastine Combo Enrolls First Patient & The High Cost of Living With MS

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a trial will test an antihistamine in combination with the diabetes medicine metformin as a way to repair the myelin sheath.He also reads the column by Ed Tobias, The MS Wire, “The High Cost of Living With MS”.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published May 4, 2022

Embed this episode

NOW PLAYING

Trial of Metformin-Clemastine Combo Enrolls First Patient & The High Cost of Living With MS

0:00 9:49

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 9 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on May 4, 2022.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!